• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Cannabinoid content in seized hashish joints from Castilla y León (Spain)].
An Sist Sanit Navar. 2025 Aug 29;48(2):e1126. doi: 10.23938/ASSN.1126.
2
Chemometric and predictive modeling of long term cannabinoid transformation in stored Cannabis sativa resin.储存的大麻树脂中大麻素长期转化的化学计量学与预测模型
Sci Rep. 2025 Sep 30;15(1):33827. doi: 10.1038/s41598-025-03888-7.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Characterising a New Cannabis Trend: Extensive Analysis of Semi-Synthetic Cannabinoid-Containing Seizures From Germany.剖析一种新型大麻趋势:对来自德国的含半合成大麻素缉获物的深入分析
Drug Test Anal. 2025 Mar 19. doi: 10.1002/dta.3886.
5
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.一种大麻衍生的“全谱”口服大麻素产品的药代动力学和药效学,该产品中大麻二酚与大麻二酚酸以及Δ9-四氢大麻酚与Δ9-四氢大麻酚酸的比例为1:1:一项双盲、安慰剂对照、受试者内人体实验室研究。
Cannabis Cannabinoid Res. 2025 Apr;10(2):e299-e313. doi: 10.1089/can.2024.0187. Epub 2025 Mar 5.
6
Cannabinoid content on product labels influences cannabis health perceptions.产品标签上的大麻素含量会影响对大麻健康的认知。
Ann Behav Med. 2025 Jan 4;59(1). doi: 10.1093/abm/kaaf046.
7
Cannabinoids for the treatment of dementia.大麻素治疗痴呆。
Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.
8
Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.荷兰大麻中Δ9-四氢大麻酚、大麻二酚和大麻酚的效力趋势:2005 - 2015年
Addiction. 2015 Dec;110(12):1941-50. doi: 10.1111/add.13082. Epub 2015 Sep 18.
9
Potency of Δ -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology.2016年英国大麻中Δ-四氢大麻酚及其他大麻素的效力:对公共卫生和药理学的影响。
Drug Test Anal. 2018 Apr;10(4):628-635. doi: 10.1002/dta.2368. Epub 2018 Feb 27.
10
Cannabinoids for fibromyalgia.用于治疗纤维肌痛的大麻素类药物。
Cochrane Database Syst Rev. 2016 Jul 18;7(7):CD011694. doi: 10.1002/14651858.CD011694.pub2.

本文引用的文献

1
Use of Cannabis and Cannabinoids for Treatment of Cancer.大麻和大麻素在癌症治疗中的应用。
Cancers (Basel). 2022 Oct 20;14(20):5142. doi: 10.3390/cancers14205142.
2
Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.确定急性 Δ-四氢大麻酚(Δ-THC)引起的驾驶和认知障碍的程度和持续时间:系统评价和荟萃分析。
Neurosci Biobehav Rev. 2021 Jul;126:175-193. doi: 10.1016/j.neubiorev.2021.01.003. Epub 2021 Jan 23.
3
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence.大麻二酚用于治疗焦虑症:临床前和临床证据的简要综述。
Cannabis Cannabinoid Res. 2020 Sep 2;5(3):191-196. doi: 10.1089/can.2019.0052. eCollection 2020.
4
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.大麻二酚用于治疗大麻使用障碍:一项2a期、双盲、安慰剂对照、随机、适应性贝叶斯试验。
Lancet Psychiatry. 2020 Oct;7(10):865-874. doi: 10.1016/S2215-0366(20)30290-X. Epub 2020 Jul 28.
5
Understanding the basics of cannabidiol from cannabis to apply to therapeutics in epilepsy.了解大麻中的大麻二酚基础知识,将其应用于癫痫治疗。
S Afr Med J. 2020 Jan 29;110(2):102-105. doi: 10.7196/SAMJ.2020.v110i2.14410.
6
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.大麻使用对欧洲各地精神病性障碍发病率差异的影响(欧盟基因-环境相互作用研究):一项多中心病例对照研究。
Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.
7
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.健康成年人中吸烟和蒸发大麻对大麻使用频率低者的急性效应:一项交叉试验。
JAMA Netw Open. 2018 Nov 2;1(7):e184841. doi: 10.1001/jamanetworkopen.2018.4841.
8
Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.非依赖使用者中,大麻和烟草对药物奖赏加工的单独和联合作用。
Psychopharmacology (Berl). 2017 Nov;234(21):3153-3163. doi: 10.1007/s00213-017-4698-2. Epub 2017 Jul 22.
9
The Standard Joint Unit.标准联合单元
Drug Alcohol Depend. 2017 Jul 1;176:109-116. doi: 10.1016/j.drugalcdep.2017.03.010. Epub 2017 May 16.
10
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.大麻使用的持续时间、频率和类型对精神病发作后头两年复发的影响:一项观察性研究。
Lancet Psychiatry. 2016 Oct;3(10):947-953. doi: 10.1016/S2215-0366(16)30188-2. Epub 2016 Aug 23.

[Cannabinoid content in seized hashish joints from Castilla y León (Spain)].

作者信息

Tejedor-Tejada Eduardo, Tejedor Muñoz Jesús Miguel

机构信息

Hospital General de Segovia. Servicio de Farmacia Hospitalaria. Segovia. España.

Delegación del Gobierno en Castilla y León. Área de Sanidad y Política Social. Valladolid. España.

出版信息

An Sist Sanit Navar. 2025 Aug 29;48(2):e1126. doi: 10.23938/ASSN.1126.

DOI:10.23938/ASSN.1126
PMID:40878770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12481414/
Abstract

BACKGROUND

Cannabis, in both its herbal form and resin-derived products, is the most widely consumed illicit drug worldwide. This study aimed to determine the potency and dosage of the primary cannabinoids present in cannabis resin from joints circulating in the region.

METHODS

A descriptive study was conducted on seized joints confiscated by law enforcement agencies in the Autonomous Community of Castilla y León (Spain) between 2017 and 2020. Gross (whole joint) and net (filler) weights were recorded. Gas chromatography was used to quantify cannabinoids delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol. Potency (percentage content) and dosage (mg) were calculated and bioavailability was estimated at 10% and 25%.

RESULTS

A total of 639 joints containing a mixture of cannabis resin and tobacco were analyzed (34.3% of confiscated samples). Both gross and net weights showed a decreasing trend over time (6.5-8.5%). Median potency values for delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol were 7.58%, 0.62%, and 0.60%, respectively, while corresponding dosages were 57.04 mg, 4.57 mg, and 4.46 mg. Overall potency and dosage declined across the study period for THC (13.5%), CBN (73%) and CBD (52-67%).

CONCLUSIONS

The delta-9-tetrahydrocannabinol potency and dosage found in confiscated cannabis resin joints during the study period were higher than those typically reported for herbal cannabis joints, suggesting greater user exposure and increased potential health risks.

摘要